Skip to main content

Want a detailed portfolio tracker?

Lyell Immunopharma (LYEL) P/E (2021 - 2026)

Lyell Immunopharma (LYEL) P/E from Jun 17, 2021 to Jul 21, 2026. The TTM Lyell Immunopharma (LYEL) P/E is -1.04. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Lyell Immunopharma (LYEL)

YearP/EChange
2026-1.04-48.92%
2025-2.05+296.82%
2024-0.52-79.85%
2023-2.56-22.49%
2022-3.30-58.62%
2021-7.98N/A

Comparison Lyell Immunopharma (LYEL) P/E with competitors

Lyell Immunopharma (LYEL) P/E is -1.04.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.16%
NBYStablecoin Development Corp0.00-100.41%
ENLVEnlivex Ltd0.07-107.16%
FGENFibroGen Inc0.24-122.97%
CHRSCoherus Biosciences Inc0.85-181.21%
FBIOFortress Biotech Inc0.95-190.83%
ORMPOramed Pharmaceuticals Inc1.50-243.86%
AGENAgenus Inc3.01-388.06%
INVAInnoviva Inc3.15-401.88%
VXRTVaxart Inc3.55-439.75%
CRMDCorMedix Inc3.63-447.28%
CVACCureVac N.V.4.45-525.50%
GLPGGalapagos NV4.86-565.05%
SRPTSarepta Therapeutics Inc4.88-567.27%
ABEOAbeona Therapeutics Inc5.39-615.65%
ABUSArbutus Biopharma Corp5.60-635.57%
ZVRAZevra Therapeutics Inc5.89-663.48%
SPROSpero Therapeutics Inc6.23-696.13%
CGENCompugen Ltd6.31-704.32%
RIGLRigel Pharmaceuticals6.87-757.74%
SLXNSilexion Therapeutics Corp7.30-798.32%
OMEROmeros Corporation9.26-986.17%
AUPHAurinia Pharmaceuticals Inc9.58-1017.39%
PLXProtalix BioTherapeutics Inc10.89-1142.40%
ACADAcadia Pharmaceuticals Inc11.73-1222.56%
TBPHTheravance Biopharma Inc12.26-1273.63%
ADMAAdma Biologics Inc12.42-1288.56%
HRMYHarmony Biosciences Holdings Inc13.82-1422.76%
SABSSAB Biotherapeutics Inc14.14-1453.00%
NAGENiagen Bioscience Inc14.82-1518.27%
INCYIncyte Corp15.82-1614.41%
REGNRegeneron Pharmaceuticals Inc15.86-1617.67%
PBYIPuma Biotechnology Inc17.32-1757.32%
CPRXCatalyst Pharmaceuticals Inc17.44-1769.15%
EXELExelixis Inc17.54-1778.60%
TGTXTG Therapeutics Inc18.97-1915.28%
MDXGMimedx Group Inc20.55-2067.12%
XOMAXOMA Royalty Corp22.87-2289.44%
ARGXArgen X SE24.30-2425.67%
CTMXCytomX Therapeutics Inc24.82-2475.74%
XOMAOXOMA Royalty Corp25.34-2525.87%
HALOHalozyme Therapeutics Inc25.62-2552.56%
XOMAPXOMA Royalty Corp25.67-2557.00%
VRTXVertex Pharmaceuticals Inc27.99-2779.50%
RPRXRoyalty Pharma plc - Class A28.69-2845.81%
SLNOSoleno Therapeutics Inc29.02-2877.19%
ASNDAscendis Pharma A/S30.09-2979.62%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3728.73%
APLSApellis Pharmaceuticals Inc39.02-3834.90%
BMRNBiomarin Pharmaceutical Inc42.21-4140.29%
KRYSKrystal Biotech Inc45.34-4440.03%
ONCBeiGene Ltd69.54-6756.04%
PHARPharming Group N.V.75.03-7281.04%
TECHBio-Techne Corp101.96-9858.91%
VCELVericel Corp109.92-10621.08%
ALNYAlnylam Pharmaceuticals Inc117.96-11390.98%
GMABGenmab140.29-13527.88%
TLXTelix Pharmaceuticals Ltd162.15-15620.40%
CORTCorcept Therapeutics Inc212.86-20473.58%